Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance[v3] Preprints.org of the Federal Food, Drug, and Cosmetic Act (FDCA).* Big FDA review coming this July. Here's what athletes and patients should know about BPC 157, TB 500, and the broader peptide conversation. Always speak with your physician before starting any new protocol. #bpc157 #